Cargando…

Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure

Detalles Bibliográficos
Autores principales:	Bavendiek, Udo, Aguirre Davila, Lukas, Koch, Armin, Bauersachs, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837211/ https://www.ncbi.nlm.nih.gov/pubmed/28065909 http://dx.doi.org/10.1093/eurheartj/ehw577

Ejemplares similares

Digoxin–mortality: randomized vs. observational comparison in the DIG trial
por: Aguirre Dávila, Lukas, et al.
Publicado: (2019)

Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation
por: Packer, Milton
Publicado: (2019)

Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022)

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology
por: Maack, Christoph, et al.
Publicado: (2018)

Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
por: Paquette, Miney, et al.
Publicado: (2020)

Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?
por: Jain, Shreepal, et al.
Publicado: (2009)

Can Pediatric Heart Failure Therapy Be Improved? Yes It Can, But…
por: Schranz, Dietmar
Publicado: (2022)

Digoxin in Atrial Fibrillation: An Old Topic Revisited
por: Ferrari, Filipe, et al.
Publicado: (2020)

Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality
por: Chamaria, Surbhi, et al.
Publicado: (2015)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
por: Colella, Antonella, et al.
Publicado: (2022)

Anti-androgenic therapy with finasteride in patients with chronic heart failure - a retrospective propensity score based analysis
por: Kattih, Badder, et al.
Publicado: (2019)

Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione
por: Kaesemeyer, Wayne, et al.
Publicado: (2021)

‘Digoxin conundrum – Time for validation?’
por: Yadava, O.P.
Publicado: (2021)

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
por: Zeng, Wu-Tao, et al.
Publicado: (2016)

Benefits of prescribing low-dose digoxin in atrial fibrillation
por: Rosca, Ciprian Ilie, et al.
Publicado: (2021)

Egyptian Atherosclerosis and Vascular Biology Association Consensus on the Use of Sodium Glucose Cotransporter-2 Inhibitors in Heart Failure with Reduced Ejection Fraction
por: Elserafy, Ahmed S., et al.
Publicado: (2021)

Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial
por: Shojaee, Majid, et al.
Publicado: (2017)

Comparison of creatinine‐based equations for estimating renal function for digoxin dose adjustment in patients with atrial fibrillation and heart failure
por: Sakai, Masahiro, et al.
Publicado: (2023)

The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016
por: Mathur, Anthony, et al.
Publicado: (2017)

Echocardiographic Parameters to Predict Atrial Fibrillation in Clinical Routine—The EAHsy-AF Risk Score
por: Sieweke, Jan-Thorben, et al.
Publicado: (2022)

Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
por: Bavendiek, Udo, et al.
Publicado: (2019)

Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
por: Lin, Yubi, et al.
Publicado: (2017)

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial
por: Eisen, Alon, et al.
Publicado: (2017)

Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
por: Hirai, Toshinori, et al.
Publicado: (2022)

Utilization of Digoxin among Hospitalized Older Patients with Heart Failure and Atrial Fibrillation in Thailand: Prevalence, Associated Factors, and Clinical Outcomes
por: Singkham, Noppaket, et al.
Publicado: (2021)

Septal total atrial conduction time for prediction of atrial fibrillation in embolic stroke of unknown source: a pilot study
por: Sieweke, Jan-Thorben, et al.
Publicado: (2019)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
por: Lai, Kuan-Cheng, et al.
Publicado: (2018)

Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study
por: Pastori, Daniele, et al.
Publicado: (2018)

Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation
por: Kytö, Ville, et al.
Publicado: (2022)

Survival Versus Attraction Advantages and Talent Selection in Sport
por: Baker, Joseph, et al.
Publicado: (2022)

Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease
por: Hooker, Deborah S., et al.
Publicado: (2021)

Human flora‐associated rodents – does the data support the assumptions?
por: Silley, Peter
Publicado: (2009)

Evidence-Based Medicine and Healthcare Quality in the Context of Information Failure: The Case of the UK Fertility Sector
por: Zhu, Minyan
Publicado: (2021)

Embedding Physical Activity in the Heart of the NHS: The Need for a Whole-System Approach
por: Speake, Helen, et al.
Publicado: (2016)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020)

Clinical Pharmacokinetics and Impact of Hematocrit on Monitoring and Dosing of Tacrolimus Early After Heart and Lung Transplantation
por: Sikma, Maaike A., et al.
Publicado: (2019)

Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?
por: Edan, Gilles, et al.
Publicado: (2023)

The effect of digoxin on renal function in patients with heart failure
por: Shah, Parin, et al.
Publicado: (2021)

Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Wang, Xiaoxu, et al.
Publicado: (2021)

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society
por: Nordestgaard, Børge G., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7mikur3m1n6h5bhi581lbro3tp